Cargando…

Untangling Amyloidosis: Recent Advances in Cardiac Amyloidosis

Cardiac amyloidosis (CA) is a highly underdiagnosed cause of heart failure. Amyloid light-chain (AL) and amyloid transthyretin (ATTR) cardiomyopathy are two major subtypes of cardiac amyloid. Amyloid fibril deposits cause cardiac dysfunction by mechanically infiltrating the myocardium or by direct c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Darae, Choi, Jin-Oh, Kim, Kihyun, Kim, Seok Jin, Jeon, Eun-Seok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Heart Failure 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536724/ https://www.ncbi.nlm.nih.gov/pubmed/36262171 http://dx.doi.org/10.36628/ijhf.2020.0016

Ejemplares similares

Clinical and prognostic implications of capillary density in patients with cardiac light chain amyloidosis
por: Kim, Darae, et al.
Publicado: (2021)

Associations of Electrocardiographic Parameters with Left Ventricular Longitudinal Strain and Prognosis in Cardiac Light Chain Amyloidosis
por: Kim, Darae, et al.
Publicado: (2019)

Prognostic Implication of Longitudinal Changes of Left Ventricular Global Strain After Chemotherapy in Cardiac Light Chain Amyloidosis
por: Bak, Minjung, et al.
Publicado: (2022)

Prognostic values of novel biomarkers in patients with AL amyloidosis
por: Kim, Darae, et al.
Publicado: (2019)

Corrigendum: Prognostic implication of longitudinal changes of left ventricular global strain after chemotherapy in cardiac light chain amyloidosis
por: Bak, Minjung, et al.
Publicado: (2022)

A Novel Transthyretin Gene Mutation in Hereditary Transthyretin Amyloidosis: A Case Series of Met13dup Patients
por: Jeon, Kina, et al.
Publicado: (2023)

Direct comparison of diagnostic and clinical values between Tc-99 m DPD and Tc-99 m PYP scintigraphy in patients with cardiac amyloidosis
por: Park, Yong-Jin, et al.
Publicado: (2023)

Incidence, Cause of Death, and Survival of Amyloidosis in Korea: A Retrospective Population-Based Study
por: Jang, Shin Yi, et al.
Publicado: (2021)

Outcomes of bortezomib combination chemotherapies in autologous stem cell transplantation-ineligible patients with AL amyloidosis
por: Hur, Joon Young, et al.
Publicado: (2021)

(99m)Tc-DPD scintigraphy and SPECT/CT in patients with AL and ATTR type amyloidosis: Potential clinical implications
por: Lee, Joohee, et al.
Publicado: (2020)

Cardiac Amyloidosis Determines the Prognosis of Systemic Amyloidosis; Roles and Responsibilities of Cardiologist
por: Lee, Ga Yeon, et al.
Publicado: (2013)

Untangling the clinical and economic burden of hospitalization for cardiac amyloidosis in the United States
por: Quock, Tiffany P, et al.
Publicado: (2019)

Cardiac amyloidosis: diagnostic challenges and recent advancement in the treatment of transthyretin amyloidosis (ATTR)
por: Rahman, Tanvir, et al.
Publicado: (2021)

Advanced Imaging in Cardiac Amyloidosis
por: Waldmeier, Dominik, et al.
Publicado: (2022)

Clinical features and outcomes of systemic amyloidosis with gastrointestinal involvement: a single-center experience
por: Lim, A Young, et al.
Publicado: (2015)

Recent advances in transthyretin amyloidosis therapy
por: Ueda, Mitsuharu, et al.
Publicado: (2014)

Contemporary Imaging Diagnosis of Cardiac Amyloidosis
por: Lee, Seung-Pyo, et al.
Publicado: (2019)

Characteristics of South Korean Patients with Hereditary Transthyretin Amyloidosis
por: Choi, Kyomin, et al.
Publicado: (2018)

Recent Advances and Current Dilemmas in the Diagnosis and Management of Transthyretin Cardiac Amyloidosis
por: Addison, Daniel, et al.
Publicado: (2021)

Advance of echocardiography in cardiac amyloidosis
por: Liang, Shichu, et al.
Publicado: (2023)

Cardiac Amyloidosis Diagnosed by Endomyocardial Biopsy
por: Kim, Myung A, et al.
Publicado: (1988)

Advances in the Treatment of Cardiac Amyloidosis
por: Macedo, Ariane Vieira Scarlatelli, et al.
Publicado: (2020)

Cardiac Amyloidosis Treatment
por: Stern, Lily K., et al.
Publicado: (2022)

Incidence, Diagnosis and Prognosis of Cardiac Amyloidosis
por: Lee, Min-Ho, et al.
Publicado: (2013)

Arrhythmias in Cardiac Amyloidosis
por: John, Roy M.
Publicado: (2018)

Transthyretin cardiac amyloidosis
por: Porcari, Aldostefano, et al.
Publicado: (2022)

Multimodal Imaging and Biomarkers in Cardiac Amyloidosis
por: Jung, Mi-Hyang, et al.
Publicado: (2022)

Recurrent mutations of MAPK pathway genes in multiple myeloma but not in amyloid light-chain amyloidosis
por: Kim, Seok Jin, et al.
Publicado: (2016)

Cardiac Amyloidosis
por: Elbdri, Salah, et al.
Publicado: (2021)

Recent advances in understanding and treating immunoglobulin light chain amyloidosis
por: Badar, Talha, et al.
Publicado: (2018)

Eyes on amyloidosis: microvascular retinal dysfunction in cardiac amyloidosis
por: Zampiccoli, Emanuel, et al.
Publicado: (2022)

Molecular Mechanisms of Cardiac Amyloidosis
por: Saito, Yukihiro, et al.
Publicado: (2021)

Future Directions in Cardiac Amyloidosis
por: Trachtenberg, Barry
Publicado: (2022)

Tissue Characterization in Cardiac Amyloidosis
por: Musetti, Veronica, et al.
Publicado: (2022)

State of the Art of Cardiac Amyloidosis
por: Belfeki, Nabil, et al.
Publicado: (2023)

Acquired Factor X Deficiency in Light Chain Amyloidosis: A Report of 2 Korean Cases
por: Ma, Youngeun, et al.
Publicado: (2011)

Imaging cardiac innervation in amyloidosis
por: Slart, Riemer H. J. A., et al.
Publicado: (2017)

A review of recent advances in the diagnosis of cardiac amyloidosis, treatment of its cardiac complications, and disease-modifying therapies
por: Raval, Maharshi, et al.
Publicado: (2023)

Transthyretin cardiac amyloidosis
por: Tomoaia, Raluca, et al.
Publicado: (2021)

Embolic Infarction Associated with Cardiac Amyloidosis
por: Cho, Kyung-Hee, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_51dar5n5slt1bkqfq2lfqiggmp